Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians

Table 2 Global Impression of Perceived Difficulties (GIPD) total scores, rated by patients, parents and physicians, by ADHD subtype

	GIPD total score
	Patient rated			Parent rated			Physician rated
ADHD subtype	N	Mean	95% CI	N	Mean	95% CI	N	Mean	95% CI
All
Week 0	156	12.5	11.6 – 13.5	155	17.2	16.2 – 18.2	155	18.8	17.8 – 19.8
Week 2	157	10.5	9.6 – 11.4	148	12.6	11.7 – 13.6	158	12.6	11.8 – 13.5
Week 8	158	9.6	8.7 – 10.5	150	11.4	10.5 – 12.4	158	11.0	10.2 – 11.9
Week 24	158	9.9	8.9 – 10.9	153	11.7	10.7 – 12.7	158	12.1	11.0 – 13.1
Combined type
Week 0	79	12.6	11.4 – 13.8	79	17.8	16.4 – 19.2	79	19.6	18.3 – 21.0
Week 2	80	10.7	9.4 – 11.9	76	13.4	12.0 – 14.8	81	13.8	12.5 – 15.0
Week 8	81	10.1	8.9 – 11.3	77	11.9	10.7 – 13.2	81	12.4	11.1 – 13.7
Week 24	81	10.0	8.7 – 11.3	77	11.9	10.6 – 13.2	81	12.9	11.4 – 14.3
Predominantly inattentive type
Week 0	72	12.5	11.0 – 14.0	71	16.4	14.9 – 17.9	71	17.9	16.5 – 19.3
Week 2	72	10.1	8.8 – 11.5	67	11.7	10.4 – 13.0	72	11.3	10.3 – 12.3
Week 8	72	9.0	7.7 – 10.3	68	10.7	9.4 – 12.1	72	9.6	8.5 – 10.7
Week 24	72	9.6	8.1 – 11.1	71	11.4	9.9 – 12.8	72	11.2	9.7 – 12.6

Patient and physician ratings based on LOCF (Last Observation Carried Forward), parient ratings are for LOCF-BR (LOCF, Baseline Rater:
Values not rated by the same individual both at baseline and later on (e. g., father rated at baseline, mother rated later) were replaced
by the last value from the baseline rater (if present), otherwise the value was deleted.
CI = Confidence Interval

ISSN: 1753-2000